A First in Man Study of MABp1 in Patients With Advanced Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01021072
Recruitment Status : Completed
First Posted : November 26, 2009
Last Update Posted : October 17, 2013
Information provided by (Responsible Party):
XBiotech, Inc.